Credits Available: 4.75 hours of AMA PRA Category 1 Credit™ with ABIM MOC

Description: This curriculum is designed to enhance knowledge, competence, and confidence among oncology clinicians regarding second-line therapy for small cell lung cancer (SCLC). Learners will explore evidence-based treatment sequencing, adverse event management, and emerging clinical trial data to optimize patient outcomes.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse, Nurse Practitioner, Physician Associate/Assistant
Target Specialties: Oncology, Hematology/Oncology
Group Leader

Kelly Goodwin

Massachusetts General Hospital

thoracic oncology NP for 10+ years; enjoy coordinating oncology APP education opportunities and unique content

 

Group Co-Leader

Elizabeth Krueger

MGH Thoracic Oncology
Nurse practitioner

I’m a thoracic onc NP at MGH with an interest in improving symptom management and quality of life for our patients.